Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shunfeng is the name of a pharmaceutical product manufactured by Guangdong CR Shunfeng Pharmaceutical Co., Ltd. The specific formulation or active ingredient for a drug called "Shunfeng" is not clearly identified in the available sources. However, Guangdong CR Shunfeng Pharmaceutical Co., Ltd. is known to manufacture various pharmaceutical products, including topical ointments such as hydrocortisone ointment (marketed as 999 ITCH RELIEVING), which are used for anti-inflammatory and antipruritic purposes[9]. The company also produces other medications that may target nervous system diseases, hemic and lymphatic diseases, immune system diseases, and infectious diseases[1]. There is no evidence that "Shunfeng" refers to a single unique active pharmaceutical ingredient or combination drug; it appears more likely to be a brand or trade name associated with multiple products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shunfeng.